While the identities of the officials involved have not been publicly detailed, sources indicated that the inquiry will examine decision-making processes and procurement practices followed during a specific period. Officials said the probe aims to assess whether due procedures were followed in awarding contracts and sourcing medicines, and whether there was any financial mismanagement or deviation from norms. The investigation is expected to involve scrutiny of procurement records, vendor selection processes, and supply chain documentation.
The move is being seen as part of a broader effort by the administration to address complaints related to governance and service delivery in public healthcare institutions. Government hospitals in Delhi cater to a large population, making procurement systems critical to ensuring uninterrupted availability of essential medicines and equipment.
No official timeline has been announced for the completion of the probe. However, authorities indicated that appropriate action would be taken based on the findings of the inquiry. The development comes at a time when public healthcare systems continue to face pressure to maintain efficiency and accountability. Experts have often pointed out that transparent procurement practices are key to both cost control and quality assurance in government-run medical facilities. Further updates are expected as the investigation progresses and more details emerge from the inquiry.